Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models.

Molecular imaging and biology·2026
Same author

CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity.

European journal of nuclear medicine and molecular imaging·2026
Same author

Factors Influencing Double-Strand Break Focus Biodosimetry for Detection of Internal Low-LET Irradiation in Human Blood Samples.

Radiation research·2026
Same author

Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced Osteomalacia.

Molecular imaging and biology·2026
Same author

Prognostic impact of discordant lesions on [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasms.

Frontiers in nuclear medicine·2026

相关实验视频

Updated: Jul 27, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K

在血液瘤学中的治疗术.

Andreas K Buck1, Sebastian E Serfling2, Sabrina Kraus3

  • 1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany; buck_a@ukw.de.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
|June 8, 2023
PubMed
概括
此摘要是机器生成的。

放射性免疫疗法和CXCR4向成像正在推进血液瘤学. 这些治疗方法改善了癌症的检测和治疗,包括急性髓性白血病和淋巴瘤.

关键词:
C-X-C 基因化基因受体 4 基因化基因受体CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4C血液瘤学 血液瘤学淋巴瘤淋巴瘤是什么放射性免疫疗法是一种放射性免疫疗法.他们是天文学家.

更多相关视频

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

1.7K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.5K

相关实验视频

Last Updated: Jul 27, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K
Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

1.7K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.5K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 核医学就是核医学.

背景情况:

  • 自2000年代初以来,抗体介导的放射性免疫疗法对血液性瘤显示出了有利的结果.
  • 已批准的治疗方法包括90Y-ibritumomabtiuxetan和131I-tositumomab用于特定的淋巴瘤类型.
  • 新兴应用涉及C-X-C动机化学因子受体4 (CXCR4) 导向的成像和治疗.

研究的目的:

  • 为血液瘤学提供目前治疗神经瘤学进展的概述.
  • 突出CXCR4向分子成像和放射性连接体治疗的新兴临床应用.
  • 讨论治疗药物在血液恶性瘤患者选择和治疗计划中的作用.

主要方法:

  • 重大临床试验和FDA批准的放射性免疫疗法 (例如90Y-ibritumomab tiuxetan,131I-tositumomab) 的审查.
  • 对急性髓性白血病中131I-anti-CD45抗体 (Iomab-B) 的SIERRAIII期试验的中间结果的分析.
  • 探索CXCR4导向的PET/CT用于疾病检测和患者选择放射性干治疗.

主要成果:

  • 放射性免疫治疗导致FDA批准治疗耐火性淋巴瘤.
  • 131I-anti-CD45抗体在复发性/耐药性急性髓性白血病中表现出有益作用.
  • 导向CXCR4的PET/CT和放射性连接体疗法在淋巴瘤中显示出有效性,包括骨髓切除和促进干细胞移植.

结论:

  • 血液瘤学中的治疗术已经显著扩大,提供了更好的诊断和治疗选择.
  • 针对CXCR4的图像驾驶放射性联体疗法提供了强大的抗淋巴瘤疗效,并使干细胞移植成为可能.
  • 新兴的治疗术策略有望改善血液性恶性瘤的管理.